Center-Authored Papers

Filters: Author is Pike, Malcolm C  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
2008
Palmieri RT, Wilson MA, Iversen ES, Clyde MA, Calingaert B, Moorman PG, Poole C, Anderson RA, Anderson S, Anton-Culver H et al..  2008.  Polymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white women.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 17(12):3567-72. Abstract
2010
Johnatty SE, Beesley J, Chen X, Macgregor S, Duffy DL, Spurdle AB, Defazio A, Gava N, Webb PM, Rossing MA et al..  2010.  Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot".. PLoS genetics. 6(7):e1001016. Abstract
Goode EL, Chenevix-Trench G, Song H, Ramus SJ, Notaridou M, Lawrenson K, Widschwendter M, Vierkant RA, Larson MC, Kjaer SK et al..  2010.  A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.. Nature genetics. 42(10):874-9. Abstract
Phelan CM, Tsai Y-Y, Goode EL, Vierkant RA, Fridley BL, Beesley J, Chen X, Webb PM, Chanock S, Cramer DW et al..  2010.  Polymorphism in the GALNT1 gene and epithelial ovarian cancer in non-Hispanic white women: the Ovarian Cancer Association Consortium.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 19(2):600-4. Abstract
Doherty JA, Rossing MA, Cushing-Haugen KL, Chen C, Van Den Berg DJ, Wu AH, Pike MC, Ness RB, Moysich K, Chenevix-Trench G et al..  2010.  ESR1/SYNE1 polymorphism and invasive epithelial ovarian cancer risk: an Ovarian Cancer Association Consortium study.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 19(1):245-50. Abstract
2011
Pharoah PDP, Palmieri RT, Ramus SJ, Gayther SA, Andrulis IL, Anton-Culver H, Antonenkova N, Antoniou AC, Goldgar D, Beattie MS et al..  2011.  The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing.. Clinical cancer research : an official journal of the American Association for Cancer Research. 17(11):3742-50. Abstract
Pearce CL, Doherty JA, Van Den Berg DJ, Moysich K, Hsu C, Cushing-Haugen KL, Conti DV, Ramus SJ, Gentry-Maharaj A, Menon U et al..  2011.  Genetic variation in insulin-like growth factor 2 may play a role in ovarian cancer risk.. Human molecular genetics. 20(11):2263-72. Abstract
Near AM, Wu AH, Templeman C, Van Den Berg DJ, Doherty JA, Rossing MA, Goode EL, Cunningham JM, Vierkant RA, Fridley BL et al..  2011.  Progesterone receptor gene polymorphisms and risk of endometriosis: results from an international collaborative effort.. Fertility and sterility. 95(1):40-5. Abstract
Notaridou M, Quaye L, Dafou D, Jones C, Song H, Høgdall E, Kjaer SK, Christensen L, Høgdall C, Blaakaer J et al..  2011.  Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancer.. International journal of cancer. Journal international du cancer. 128(9):2063-74. Abstract
Amankwah EK, Kelemen LE, Wang Q, Song H, Chenevix-Trench G, Beesley J, Webb PM, Pearce CL, Wu AH, Pike MC et al..  2011.  Prostate cancer susceptibility polymorphism rs2660753 is not associated with invasive ovarian cancer.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 20(5):1028-31. Abstract
2012
Pearce CL, Templeman C, Rossing MA, Lee A, Near AM, Webb PM, Nagle CM, Doherty JA, Cushing-Haugen KL, Wicklund KG et al..  2012.  Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies.. The lancet oncology. 13(4):385-394. Abstract
2013
Permuth-Wey J, Lawrenson K, Shen HC, Velkova A, Tyrer JP, Chen Z, Lin H-Y, Chen AY, Tsai Y-Y, Qu X et al..  2013.  Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31.. Nature communications. 4:1627. Abstract
White KL, Vierkant RA, Fogarty ZC, Charbonneau B, Block MS, Pharoah PDP, Chenevix-Trench G, Rossing MA, Cramer DW, Pearce CL et al..  2013.  Analysis of Over 10,000 Cases Finds No Association between Previously Reported Candidate Polymorphisms and Ovarian Cancer Outcome.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 22(5):987-92. Abstract
Earp MA, Kelemen LE, Magliocco AM, Swenerton KD, Chenevix-Trench G, Lu Y, Hein A, Ekici AB, Beckmann MW, Fasching PA et al..  2013.  Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA.. Human genetics. Abstract
Charbonneau B, Block MS, Bamlet WR, Vierkant RA, Kalli KR, Fogarty Z, Rider DN, Sellers TA, Tworoger SS, Poole E et al..  2013.  Risk of Ovarian Cancer and the NF-κB Pathway: Genetic association with IL1A and TNFSF10.. Cancer research. Abstract
Bojesen SE, Pooley KA, Johnatty SE, Beesley J, Michailidou K, Tyrer JP, Edwards SL, Pickett HA, Shen HC, Smart CE et al..  2013.  Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer.. Nature genetics. 45(4):371-84,384e1-2. Abstract
Pharoah PDP, Tsai Y-Y, Ramus SJ, Phelan CM, Goode EL, Lawrenson K, Buckley M, Fridley BL, Tyrer JP, Shen H et al..  2013.  GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.. Nature genetics. 45(4):362-70,370e1-2. Abstract
Sieh W, Salvador S, McGuire V, Weber RP, Terry KL, Rossing MA, Risch H, Wu AH, Webb PM, Moysich K et al..  2013.  Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies.. International journal of epidemiology. 42(2):579-89. Abstract
Pearce CL, Rossing MA, Lee AW, Ness RB, Webb PM, Chenevix-Trench G, Jordan SJ, Stram DA, Chang-Claude J, Hein R et al..  2013.  Combined and interactive effects of environmental and GWAS-identified risk factors in ovarian cancer.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Abstract
Schumacher FR, Wang Z, Skotheim RI, Koster R, Chung CC, Hildebrandt MAT, Kratz CP, Bakken AC, Timothy Bishop D, Cook MB et al..  2013.  Testicular germ cell tumor susceptibility associated with the UCK2 locus on chromosome 1q23.. Human molecular genetics. 22(13):2748-2753. Abstract
Faber MT, Kjær SK, Dehlendorff C, Chang-Claude J, Andersen KK, Høgdall E, Webb PM, Jordan SJ, Rossing MA, Doherty JA et al..  2013.  Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 case-control studies.. Cancer causes & control : CCC. 24(5):989-1004. Abstract
Shen H, Fridley BL, Song H, Lawrenson K, Cunningham JM, Ramus SJ, Cicek MS, Tyrer J, Stram D, Larson MC et al..  2013.  Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer.. Nature communications. 4:1628. Abstract
Setiawan VW, Yang HP, Pike MC, McCann SE, Yu H, Xiang Y-B, Wolk A, Wentzensen N, Weiss NS, Webb PM et al..  2013.  Type I and II Endometrial Cancers: Have They Different Risk Factors? Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 31(20):2607-18. Abstract
Olsen CM, Nagle CM, Whiteman DC, Ness R, Pearce CL, Pike MC, Rossing MA, Terry KL, Wu AH, Risch HA et al..  2013.  Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium.. Endocrine-related cancer. 20(2):251-262. Abstract
2014
Charbonneau B, Moysich KB, Kalli KR, Oberg AL, Vierkant RA, Fogarty ZC, Block MS, Maurer MJ, Goergen KM, Fridley BL et al..  2014.  Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome.. Cancer immunology research. 2(4):332-40. Abstract